1. What is Trilaciclib?
2. Indications and contraindications
3. How does Trilaciclib work?
4. Drug efficacy
5. Side effects
6. Clinics that offer Cosela
Trilaciclib is one of the most anticipated drugs of 2021. More than 2 million patients around the world need it. Because of these circumstances, the Food and Drug Administration made it a priority to review drug approval. And on Feb. 12, 2021, some 2 million patients got the good news: the FDA approved a new drug to alleviate the effects after treatment of small-cell lung cancer with chemotherapy. Since our December article on promising cancer treatments in 2021, MediGlobus has often been contacted by patients who want to know the availability of this drug. And in this article, we’ll tell our readers how the most anticipated drug of 2021 works, what its effectiveness is, and which clinics can provide treatment with Trilaciclib. Read to the end!
Listen to the artice:
WHAT IS COSELA (TRILACICLIB)?
Trilaciclib is prescribed to:
EXPERTS’ OPINION ON THE COSELA (TRILACICLIB)
“The approval of Trilaciclib (Cosela) is an important advance in the treatment of patients with advanced small-cell lung cancer receiving chemotherapy,” reports Professor Jeffrey Crawford of Duke Cancer Institute.
“Standard chemotherapy regimens damage bone marrow function and can lead to costly hospitalizations and surgeries. Cosela is the first and only therapy that helps protect bone marrow from chemotherapy-induced myelosuppression,” explains Jack Bailey, CEO of pharmaceutical company G1.
“For patients with stage 4 small-cell lung cancer, protecting bone marrow function can help make their chemotherapy safer and allow them to complete their treatment on time and as planned,” reports Albert Deisseroth, a doctor at the FDA’s Center for Drug Evaluation and Research.
INDICATIONS AND CONTRAINDICATIONS FOR TRILACICLIB
The drug is contraindicated in people with pneumonitis and interstitial lung disease. Treatment with Cosela should not be given to patients with hypersensitivity to Trilaciclib. Pregnant women are also contraindicated for this therapy.
HOW TRILACICLIB WORKS FOR LUNG CANCER
The main active ingredient in Cosela is Trilaciclib. It inhibits the activity of CDK 4/6. This means that the drug blocks the work of different kinds of cyclin-dependent kinases – enzymes that control cell activity. Suppression of CDK 4/6 activity interrupts the process of cancer cell division. This strategy works effectively to treat metastatic cancer. Additionally, it helps protect cells from the damaging effects of chemotherapeutic agents.
TRILACICLIB EFFICACY IN LUNG CANCER
The combination of chemotherapy and Cosela (Trilaciclib) prolongs and improves the lives of patients with small-cell lung cancer. They can receive chemotherapy without lowering the dose or reducing the number of courses while avoiding serious side effects.
Trilaciclib reduces the risk of neutropenia and preserves immune function. Patients feel better during therapy due to a reduction side effects of chemotherapy. After a course of Trilaciclib, patients are less prone to infections.
Thanks to Cosela (Trilaciclib), patients do not need blood transfusions or bone marrow transplants.
SIDE EFFECTS OF TRILACICLIB
About 30% of patients have difficulty breathing, low levels of calcium, potassium, and phosphate in the blood, and an increased risk of blood clots. About 10% of patients report increased fatigue and headache.
WHERE TO GET TRILACICLIB TREATMENT
Trilaciclib is available at advanced clinics that specialize in oncology. Going to foreign clinics can ensure that you get the original drug. You will be monitored by an experienced team of doctors who will help you if you have any serious side effects. You can get therapy with the Cosela at:
Submit a request for Cosela treatment
Our coordinators are ready to advise you and tell about the nuances of the medical trip. Call us or leave your contact details. We will call you back and answer all your questions. Our services are free of charge.
- 1. Small cell lung cancer – basic statistics
- 2. Official FDA approval of Trilaciclib
- 3. Information about Trilaclib on the G1 Therapeutics website
- 4. What is Cosela (Trilaciclib)